Italy Approves GSK-Vir Antibody to Treat COVID-19 Italy Approves GSK-Vir Antibody to Treat COVID-19
Italy approved the temporary distribution of a coronavirus antibody treatment by Britain ' s GlaxoSmithKline and US company Vir Biotechnology, the health ministry said in a statement.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | Infectious Diseases | Intensive Care | Italy Health | UK Health